International Journal of Clinical Case Reports, 2025, Vol.15, No.6, 271-282 http://medscipublisher.com/index.php/ijccr 280 Caballero M., Krantz M., Quirce S., Phillips E., and Stone C., 2021, Hidden dangers: recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions, The Journal of Allergy and Clinical Immunology, In Practice, 9(8): 2968-2982. https://doi.org/10.1016/j.jaip.2021.03.002 Cabanillas B., and Novak N., 2021, Allergy to COVID-19 vaccines: a current update, Allergology International, 70: 313-318. https://doi.org/10.1016/j.alit.2021.04.003 David S., and Buhlmann A., 2025, Der anaphylactic shock, Deutsche Medizinische Wochenschrift, 150(7): 342-346. https://doi.org/10.1055/a-2288-2323 Dvorak A., Ma G., Schulman E., Lichtenstein L., and Dvorak H., 1983, Basophil and mast cell degranulation: ultrastructural analysis of mechanisms of mediator release, Federation Proceedings, 42(8): 2510-2515. Ebisawa M., Muraro A., Worm M., Katelaris C., Pouessel G., Ring J., Toit G., and Fox A., 2025, Optimizing adrenaline administration in anaphylaxis: clinical practice considerations and safety insights, Clinical and Translational Allergy, 15(8): e70085. https://doi.org/10.1002/clt2.70085 Ebo D., Beyens M., Heremans K., Van Der Poorten M., Van Gasse A., Mertens C., Houdt M., Sabato V., and Elst J., 2022, Recent knowledge and insights on the mechanisms of immediate hypersensitivity and anaphylaxis: Ige/Fcεri-and Non-Ige/Fcεri-dependent, Current Pharmaceutical Design, 29(3): 178-184. https://doi.org/10.2174/1381612829666221025091827 Furuto Y., Nohara T., Hamada H., and Shibuya Y., 2022, Hypertensive anaphylaxis after moderna COVID-19 vaccination: a case report, Cureus, 14(6): e25586. https://doi.org/10.7759/cureus.25586 Hong A., and Sardinas G., 2022, Suspected anaphylactic reaction following second dose of the Pfizer-BioNTech (BNT162b2) coronavirus vaccine in a geriatric female, HCA Healthcare Journal of Medicine, 3(6): 349. https://doi.org/10.36518/2689-0216.1452 Hung S., Preclaro I., Chung W., and Wang C., 2022, Immediate hypersensitivity reactions induced by COVID-19 vaccines: current trends potential mechanisms and prevention strategies, Biomedicines, 10(6): 1260. https://doi.org/10.3390/biomedicines10061260 Ieven T., Vandebotermet M., Nuyttens L., Devolder D., Vandenberghe P., Bullens D., and Schrijvers R., 2022, COVID-19 vaccination safety and tolerability in patients allegedly at high risk for immediate hypersensitivity reactions, Vaccines, 10(2): 286. https://doi.org/10.3390/vaccines10020286 Kim M., Lee Y., Kim S., Kim J., Min T., Park H., Shin M., Ye Y., Lee S., Lee J., Choi J., Jang G., and Chang Y., 2021, COVID-19 vaccine-associated anaphylaxis and allergic reactions: consensus statements of the kaaaci urticaria/angioedema/anaphylaxis working group, Allergy Asthma and Immunology Research, 13: 526-544. https://doi.org/10.4168/aair.2021.13.4.526 Klosko R., Lynch S., Cabral D., Nagaraju K., Johnston Y., Steinberg J., and McCall K., 2023, Death and disability reported with cases of vaccine anaphylaxis stratified by administration setting: an analysis of the vaccine adverse event reporting system from 2017 to 2022, Vaccines, 11(2): 276. https://doi.org/10.3390/vaccines11020276 Kounis N., Koniari I., De Gregorio C., Velissaris D., Petalas K., Brinia A., Assimakopoulos S., Gogos C., Kouni S., Kounis G., Calogiuri G., and Hung M., 2021, Allergic reactions to current available COVID-19 vaccinations: pathophysiology causality and therapeutic considerations, Vaccines, 9(3): 221. https://doi.org/10.3390/vaccines9030221 Kozma G., Mészáros T., Berényi P., Facskó R., Patkó Z., Oláh C., Nagy A., Fülöp T., Glatter K., Radovits T., Merkely B., and Szebeni J., 2023, Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing covid-19 vaccines: evidence for immunogenicity of PEG, Vaccine, 41(31): 4561-4570. https://doi.org/10.1016/j.vaccine.2023.06.009 Laisuan W., 2021, COVID-19 Vaccine anaphylaxis: current evidence and future approaches, Frontiers in Allergy, 2: 801322. https://doi.org/10.3389/falgy.2021.801322 Luxi N., Giovanazzi A., Arcolaci A., Bonadonna P., Crivellaro M., Cutroneo P., Ferrajolo C., Furci F., Guidolin L., Moretti U., Olivieri E., Petrelli G., Zanoni G., Senna G., and Trifirò G., 2022, Allergic reactions to COVID-19 vaccines: risk factors frequency mechanisms and management, Biodrugs, 36: 443-458. https://doi.org/10.1007/s40259-022-00536-8 Lyons D., Murray C., Hannigan S., Sui J., Alamin S., Conlon N., Keogan M., Khalib K., Fitzpatrick C., Hourihane J., Carey M., and Edgar J., 2022, Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic, Clinical and Experimental Immunology, 209: 182-187. https://doi.org/10.1093/cei/uxac064 Liu J.M., 2025, Nursing monitoring and immunological trends after influenza vaccination in institutionalized elderly populations, International Journal of Clinical Case Reports, 15(4): 190-199. https://doi.org/10.5376/ijccr.2025.15.0020 Mencarelli A., Bist P., Choi H., Khameneh H., Mortellaro A., and Abraham S., 2024, Anaphylactic degranulation by mast cells requires the mobilization of inflammasome components, Nature Immunology, 25(4): 693-702. https://doi.org/10.1038/s41590-024-01788-y Mok D., and Chan K., 2020, The effects of pre-existing antibodies on live-attenuated viral vaccines, Viruses, 12(5): 520. https://doi.org/10.3390/v12050520
RkJQdWJsaXNoZXIy MjQ4ODYzNA==